NCT06111391

Brief Summary

This study aimed to evaluate patient satisfaction (VAS) , prosthetic outcomes and clinical outcomes of polyether ether ketone (PEEK) Versus Titanium Zirconium fixed prostheses supported by six maxillary implants and opposed by distal extension removable partial denture.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 15, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 12, 2023

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 2, 2023

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 20, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

November 1, 2023

Completed
Last Updated

November 1, 2023

Status Verified

February 1, 2022

Enrollment Period

11 months

First QC Date

October 20, 2023

Last Update Submit

October 26, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • implant stability

    After transmucosal abutments were removed and the smart pegs were attached to the fixtures, resonance frequency analysis was done to assess implant stability.The implant stability quotient (ISQ) was used to quantify stability via the Osstell® device (Integration Diagnostics Ltd.).

    12 months

Study Arms (2)

maxillary titanium zirconium full arch fixed prosthesis

ACTIVE COMPARATOR

maxillary titanium zirconium full arch fixed prosthesis and mandibular distal extension partial denture.

Device: Osstell® device (Integration Diagnostics Ltd.).

maxillary peek composite full arch fixed prosthesis

ACTIVE COMPARATOR

maxillary peek composite full arch fixed prosthesis and mandibular distal extension partial denture.

Device: Osstell® device (Integration Diagnostics Ltd.).

Interventions

After trans-mucosal abutments were removed and the smart pegs were attached to the fixtures, resonance frequency analysis was done to assess implant stability.The implant stability quotient (ISQ) was used to quantify stability via the Osstell® device (Integration Diagnostics Ltd.).

maxillary peek composite full arch fixed prosthesismaxillary titanium zirconium full arch fixed prosthesis

Eligibility Criteria

Age58 Years - 68 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Normal jaw relation Good oral hygiene Patient with class I or class II inter-rach space in order to have sufficient restoration space to construct FP3 prosthesis.

You may not qualify if:

  • Patients with TMJ disorder and heavy smokers for more than 10 cigarettes per day.
  • Uncooperative patient. Unfavorable occlusion. Limited restoration space (less than 12 mm).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura university

Al Mansurah, 35516, Egypt

Location

Related Publications (1)

  • Wang J, Wu P, Liu HL, Zhang L, Liu LP, Ma CF, Chen JH. Polyetheretherketone versus titanium CAD-CAM framework for implant-supported fixed complete dentures: a retrospective study with up to 5-year follow-up. J Prosthodont Res. 2022 Apr 27;66(2):279-287. doi: 10.2186/jpr.JPR_D_20_00142. Epub 2021 Sep 30.

    PMID: 34588401BACKGROUND

MeSH Terms

Conditions

Patient Satisfaction

Condition Hierarchy (Ancestors)

Treatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Marwa Aboelez, Phd

    Mansoura University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 20, 2023

First Posted

November 1, 2023

Study Start

April 15, 2022

Primary Completion

March 12, 2023

Study Completion

April 2, 2023

Last Updated

November 1, 2023

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations